| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 03.5.2024 | 20:14 | BW | CORRECTING and REPLACING Aditxt Announces Pricing of $4.2.. |
| 03.5.2024 | 15:00 | BW | Aditxt Announces Pricing of $4.2 Million Private Placement.. |
| 02.4.2024 | 14:30 | BW | Aditxt Signs a Definitive Agreement to Acquire Appili.. |
| 27.3.2024 | 13:36 | PRNUS | Evofem Reports $18.2 million of Phexxi Net Product Sales in.. |
| 11.3.2024 | 21:51 | EDGAR2 | Form 8-K - Current report |
| 07.3.2024 | 13:54 | PRNUS | For Women Using GLP-1 Receptor Agonists who take Oral Birth.. |
| 04.3.2024 | 23:27 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 04.3.2024 | 23:24 | EDGAR2 | Form 8-K - Current report |
| 01.3.2024 | 22:01 | EDGAR2 | Form 8-K - Current report |
| 29.2.2024 | 22:01 | EDGAR2 | Form 8-K - Current report |
| 22.2.2024 | 23:21 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 21.2.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 16.2.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 15.2.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 14.2.2024 | 15:26 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
| 09.2.2024 | 22:31 | EDGAR2 | Form 8-K - Current report |
| 06.2.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 02.2.2024 | 22:28 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 02.2.2024 | 22:26 | EDGAR2 | Form 8-K - Current report |
| 01.2.2024 | 14:00 | PRNUS | Evofem Biosciences Announces Strong Preliminary Results,.. |
| 30.1.2024 | 23:28 | EDGAR2 | Form 8-K - Current report |
| 30.1.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 30.1.2024 | 14:30 | BW | Aditxt, Inc. Acquires Proprietary Electroencephalography.. |
| 23.1.2024 | 22:18 | EDGAR2 | Form D - Notice of Exempt Offering of Securities |
| 19.1.2024 | 22:15 | EDGAR2 | Form 8-K - Current report |
| 18.1.2024 | 22:30 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
| 09.1.2024 | 23:19 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 09.1.2024 | 23:16 | EDGAR2 | Form 8-K - Current report |
| 08.1.2024 | 14:30 | BW | Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life.. |
| 05.1.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 05.1.2024 | 14:45 | EDGAR2 | Form 8-K - Current report |
| 05.1.2024 | 14:30 | BW | Aditxt Announces Closing of $6.0 Million Private Placement.. |
| 02.1.2024 | 14:45 | EDGAR2 | Form 8-K - Current report |
| 02.1.2024 | 14:30 | BW | Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’.. |
| 29.12.2023 | 23:07 | BW | Aditxt Announces $6 Million Private Placement Priced.. |
| 26.12.2023 | 23:26 | EDGAR2 | Form 8-K - Current report |
| 22.12.2023 | 23:00 | EDGAR2 | Form 8-K - Current report |
| 22.12.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 21.12.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 12.12.2023 | 23:09 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 12.12.2023 | 23:04 | EDGAR2 | Form 8-K - Current report |
| 12.12.2023 | 14:30 | BW | Aditxt, Inc. Enters into Definitive Agreement to Acquire.. |
| 08.12.2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 01.12.2023 | 22:39 | EDGAR2 | Form 8-K - Current report |
| 16.11.2023 | 22:30 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 13.11.2023 | 22:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 13.11.2023 | 22:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 13.11.2023 | 22:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 13.11.2023 | 22:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 09.11.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
